Axcan Pharma 40-F/A 2004 FY Annual report (Canada) (amended)

Exhibit 99.8

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Axcan Pharma Inc. (the "Company") on Form 40-F for the period ending September 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, JeanVezina, Vice President, Finance and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/  JEAN VEZINA      Jean Vezina
Vice President, Finance and Chief Financial Officer
February 17, 2005